Read the Latest
Children's Hospital is part of the UPMC family.
Be safe anytime, anywhere.
To find a pediatrician or pediatric specialist, please call 412-692-7337 or search our directory.
A resource for our network of referring physicians.
For more information about research, please call our main office at 412-692-6438.
Ranked #6 Nationally by U.S. News & World Report.
Some of the many Cancer and Blood Disorders research opportunities available related to leukemia are listed below. Select a study to review a brief description and requirements. Parents or guardians of children who might be eligible are encouraged to inquire about enrollment. Contact information is provided at the end of each study.
Please note that Pilot and Phase I studies are the most experimental and should be considered only after other treatments or trials have been attempted without success.
Thank you for exploring these opportunities and helping us to find cures and prevent childhood disease.
AALL1731: A Study to Compare the Addition of Blinatumomab in Combination with Chemotherapy in Patients Diagnosed with Standard-risk B-cell Acute Lymphoblastic Leukemia, and the Treatment of Patients with Localized B-cell Lymphoblastic Lymphoma
AALL05B1: Proper Protocols for Collecting and Banking Relapsed Acute Lymphoblastic Leukemia Research Specimens
AALL1821: A Study to Compare Blinatumomab Alone to Blinatumomab with Nivolumab in Patients Diagnosed with First Relapse B-cell Acute Lymphoblastic Leukemia
AALL1732: A Study to Test if the Addition of Inotuzumab Ozogamicin to Standard Chemotherapy Treatment Improves Outcomes for Patients Diagnosed with National Cancer Institute High-Risk B-cell Acute Lymphoblastic Leukemia, or Standard-Risk B-cell Acute Lymphoblastic Leukemia with High-Risk Features
AAML1831: A Study to Compare Standard Chemotherapy to Therapy with CPX-351 and/or Gilteritinib for Patients with Newly Diagnosed AML with or without FLT3 Mutations
AAML1531: Risk-stratified Therapy for Acute Myeloid Leukemia in Down Syndrome
AAML1331: Study for Patients with Newly Diagnosed Acute Promyelocytic Leukemia using Arsenic Trioxide and All Trans-Retinoic Acid
ALTE05N1: Umbrella Long-Term Follow-Up Protocol for Participants with and without a History of Cancer
ALTE03N1: Key Adverse Events Following Childhood Cancer
APEC14B1: Project:Every Child, A Registry, Eligibility Screening, Biology and Outcome Study
AAML18P1: Stopping Tyrosine Kinase Inhibitors to Assess Treatment-Free Remission in Pediatric Chronic Myeloid Leukemia - Chronic Phase
AAML1921: A Study of a Drug, Bosutinib, for Treating Newly Diagnosed Chronic Phase or Resistant/Intolerant Ph+ Chronic Myeloid Leukemia
ALTE2031: StepByStep: A Trial of a Mobile Health and Social Media Physical Activity Intervention Among Adolescent and Young Adult Childhood Cancer Survivors
ALTE1631: A Web-based Physical Activity Intervention among Children and Adolescents
ADVL1521: Study of the MEK Inhibitor Trametinib in Children with Relapsed or Refractory Juvenile Myelomonocytic Leukemia
ADVL1823: Larotrectinib for Previously Untreated TRK Fusion Pediatric Solid Tumors and TRK Fusion Relapsed Pediatric Acute Leukemias
Children's Hospital's main campus is located in the Lawrenceville neighborhood. Our main hospital address is:
UPMC Children’s Hospital of Pittsburgh
One Children’s Hospital Way
4401 Penn Ave.
Pittsburgh, PA 15224
In addition to the main hospital, Children's has many convenient locations in other neighborhoods throughout the greater Pittsburgh region.
With myCHP, you can request appointments, review test results, and more.
For questions about a hospital bill call:
To pay your bill online, please visit UPMC's online bill payment system.
Interested in giving to Children's Hospital? Support the hospital by making a donation online, joining our Heroes in Healing monthly donor program, or visiting our site to learn about the other ways you can give back.